| Ms Kimberly Lamparelli, MS, CCC-SLP | |
|
432 Western Ave, Albany, NY 12203-1419 | |
| (518) 458-5354 | |
| (518) 337-2313 |
| Full Name | Ms Kimberly Lamparelli |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 432 Western Ave, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326287194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 006558 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kimberly Lamparelli, MS, CCC-SLP 432 Western Ave, Albany, NY 12203-1419 Ph: (518) 458-5354 | Ms Kimberly Lamparelli, MS, CCC-SLP 432 Western Ave, Albany, NY 12203-1419 Ph: (518) 458-5354 |
News Archive
The Johns Hopkins Brain Science Institute (BSi) announced today that it has entered into an agreement with Ortho-McNeil-Janssen Pharmaceuticals Inc. (OMJPI) to advance the development of novel therapeutics for neurological and psychiatric diseases.
Scientists are reporting a possible explanation for the bone loss that may occur following long-term use of a medicine widely used to treat epilepsy, bipolar disorder, and other conditions. The drug, valproate, appears to reduce the formation of two key proteins important for bone strength, they said. Their study, which offers a solution to a long-standing mystery, appears in ACS' monthly Journal of Proteome Research.
Researchers at Sanford-Burnham Medical Research Institute have discovered a mechanism that explains why some breast cancer tumors respond to specific chemotherapies and others do not. The findings highlight the level of glutamine, an essential nutrient for cancer development, as a determinant of breast cancer response to select anticancer therapies, and identify a marker associated with glutamine uptake, for potential prognosis and stratification of breast cancer therapy.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin (bevacizumab - Genentech/Roche) in a preclinical model of breast cancer.
Taking a cue from the semiconductor industry, a team of investigators at Stanford University has developed a method of producing unlimited quantities of highly magnetic nanoparticles suitable for use as magnetic resonance tumor imaging agents.
› Verified 2 days ago
Natalia M Martinez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Rapp Rd, Albany, NY 12203 Phone: 518-867-3061 Fax: 518-867-3066 | |
Mrs. Amy E Kaiser, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 108 Whitehall Rd, Albany, NY 12209 Phone: 518-462-7258 Fax: 518-462-7265 | |
Dr. Jessica Sofranko Kisenwether, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 432 Western Ave, Albany, NY 12203 Phone: 518-337-4777 Fax: 518-337-2313 | |
Ms. Taryn Lesvia Penebaker, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26 Computer Dr E, Albany, NY 12205 Phone: 518-438-4800 | |
Joanne Coffey, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-437-5717 | |
Miss Cristina Lynn Silva, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Communication Disorders Department Mc 128, Albany, NY 12208 Phone: 518-262-4526 | |
Anthony Richard Amitrano, MSCCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Philip St, Albany, NY 12207 Phone: 518-671-3777 |